Metabolic Consequences of Oral Administration of 24,25-Dihydroxycholecalciferol to Uremic Dogs

24,25-dihydroxycholecalciferol [24,25-(OH)(2)D(3)], once considered a relatively inert metabolite of vitamin D(3), has been recently recognized as a metabolically active product in some species. In previous studies, we have shown that infusion of 24,25(OH)(2)D(3) into the thyroid artery of normal do...

תיאור מלא

מידע ביבליוגרפי

הוצא לאור ב:	J Clin Invest
Principais autores:	Canterbury, Janet M., Gavellas, George, Bourgoignie, Jacques J., Reiss, Eric
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	American Society for Clinical Investigation 1980
נושאים:	Articles
גישה מקוונת:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC371397/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7354130/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI109701
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!